Travel Vaccines Market 2019, Industry Report, Growth, Trends, Opportunities and Forecast till 2024


Posted December 16, 2019 by ivosmith98

The global travel vaccines market is driven by increasing international tourism and favorable government initiatives promoting the benefits of vaccination.

 
According to the latest report by IMARC Group, the global travel vaccines market size reached US$ 4.9 Billion in 2018. Travel vaccines are immunization shots that travelers can get before traveling to other parts of the world where there is a high risk of developing certain diseases. These vaccines build immunity against viral and microbial invasions while improving the overall health of the individual. They introduce the disease-causing microbes into the bloodstream to help the human body develop antibodies to fight off the same, if exposed to in the future. These shots must be taken at least 4 to 6 weeks before traveling as this gives enough time for the immunization to start working efficiently.

Access complete report @ https://www.imarcgroup.com/travel-vaccines-market

Global Travel Vaccines Market Trends:

Rising occurrence of infectious and travel-related diseases such as Japanese encephalitis, diphtheria, meningitis and yellow fever is one of the major factors that are driving the growth of the market. In addition to this, owing to factors such as the rising globalization and reduced international airfares, there has been an increase in international tourism. Consequently, the sales of travel vaccines have also witnessed a significant rise across the globe. Apart from this, several combination vaccines are also available for travelers, which protect against more than one disease. They are widely gaining popularity amongst the users as they reduce the number of vaccines required. Furthermore, government bodies in several countries are investing in promoting the use of these vaccines. For instance, the National Health Service (NHS) is providing several free travel vaccines for diseases such as cholera, polio, typhoid and hepatitis A in the United Kingdom to reduce the risk of these diseases being spread across the country. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 8.1 billion by 2024, growing at a CAGR of around 9% during 2019-2024.

Request For Free Sample Pdf Copy @ https://www.imarcgroup.com/travel-vaccines-market/requestsample

Market Segmentation

Market Breakup by Composition

1. Mono Vaccines
2. Combination Vaccines

Market Breakup by Disease

1. Hepatitis A
2. DPT
3. Yellow Fever
4. Typhoid
5. Hepatitis B
6. Measles and Mumps
7. Rabies
8. Meningococcal
9. Varicella
10. Japanese Encepthalitis
11. Others

Market Breakup by Region

1. North America
2. Europe
3. Asia Pacific
4. Middle East and Africa
5. Latin America

Some of the major players operating in the industry include

Novartis AG ADR (NVS)
GlaxoSmithKline plc (GSK)
Sanofi S.A. (SAN)
Merck & Co. Inc. (MRK)
Pfizer (NYSE: PFE)
ALK-Abelló
Bavarian Nordic
Crucell N.V.
CSL Limited
MedImmune, LLC,
Altimmune
Abbott Laboratories
F. Hoffman-La Roche Ltd.
Browse related reports

Global H1N1 Vaccines Market Research Report and Forecast 2019-2024: https://www.imarcgroup.com/h1n1-vaccines-market

India Vaccine Market Research Report and Forecast 2019-2024: https://www.imarcgroup.com/indian-vaccine-market

Contact US: IMARC Group
309 2nd St, Brooklyn, NY 11215, USA
Website: www.imarcgroup.com
Email: [email protected]
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By IMARC Group
Phone 6317911145
Business Address 309 2nd St,
Brooklyn, NY, United States 11215
Country United States
Categories Business , Health , Industry
Tags industry report , market report , market research , travel vaccines
Last Updated December 16, 2019